Anti-Aging Stack
Epithalon + GHK-Cu + MOTS-c
Slow biological aging through telomere support, collagen maintenance, and mitochondrial optimization
Overview
A longevity-focused combination targeting three major aging pathways: telomere maintenance (Epithalon), extracellular matrix repair and gene expression modulation (GHK-Cu), and mitochondrial function and metabolic health (MOTS-c). This stack represents a multi-system approach to slowing biological aging.
Component Peptides
Telomerase activator — synthetic tetrapeptide based on epithalamin that may support telomere length maintenance
Gene expression modulator — resets gene expression to a more youthful pattern, stimulates collagen and elastin synthesis
Mitochondrial-derived peptide — enhances metabolic homeostasis, improves insulin sensitivity, and acts as an exercise mimetic
Expected Timeline
Energy and metabolic improvements within 2-4 weeks (MOTS-c). Skin quality improvements at 4-8 weeks (GHK-Cu). Telomere benefits, if any, would require months to years and are difficult to measure clinically.
Safety Notes
- Epithalon has limited long-term safety data outside of Russian studies
- MOTS-c may affect blood glucose — monitor if diabetic or pre-diabetic
- GHK-Cu: ensure proper copper/zinc balance with supplementation
- Theoretical concern that telomerase activation could affect cancer risk, though no evidence supports this at standard doses
- This is an advanced stack — not recommended for peptide beginners
Bloodwork Recommendations
- Telomere length testing (baseline, though expensive)
- IGF-1 levels
- Fasting glucose, HbA1c, and insulin
- Comprehensive metabolic panel
- Copper and zinc levels
- Inflammatory markers (hs-CRP, IL-6)
Contraindications
- Active cancer (telomerase activation is contraindicated)
- Copper metabolism disorders
- Diabetes (use MOTS-c with caution and monitoring)
- Pregnancy or breastfeeding
Evidence Assessment
Epithalon has some human data from Russian studies (Khavinson) showing telomerase activation and potential lifespan benefits, but these studies have limited Western peer review. GHK-Cu has solid in vitro and some in vivo data for gene expression modulation. MOTS-c has promising animal data and early human studies for metabolic effects. The combination is entirely theoretical.
References
- Khavinson VK, et al. "Peptide Regulation of Gene Expression and Protein Synthesis in Bronchial Epithelium." Lung. 2014;192(6):781-791.
- Lee C, et al. "The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance." Cell Metab. 2015;21(3):443-454.
- Pickart L, et al. "GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration." Biomed Res Int. 2015.
Research Disclaimer: The information on this page is for educational purposes only and does not constitute medical advice. All products referenced are for in vitro laboratory research use only. Consult a qualified healthcare professional before beginning any research protocol.